Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

Journal of the National Cancer Institute

Volumn 95, Issue 16, 2003, Pages 1218-1226

  Key, Timothy J ^a,h   Appleby, P N ^a   Reeves, G K ^a   Roddam, A ^a   Dorgan, J F ^b   Longcope, C ^c   Stanczyk, F Z ^d   Stephenson Jr , H E ^e   Falk, R T ^f   Miller, R ^e   Schatzkin, A ^f   Allen, D S ^g   Fentiman, I S ^g   Wang, D Y ^g   Dowsett, M ^h   Thomas, H V ⁱ   Hankinson, S E ^j,k   Toniolo, P ^l   Akhmedkhanov, A ^l   Koenig, K ^l   Shore, R E ^l   Zeleniuch Jacquotte, A ^l   Berrino, F ^m   Muti, P ^n,o   Micheli, A ^o   Krogh, V ^o   Sieri, S ^o   Pala, V ^o   Venturelli, E ^o   Secreto, G ^o   Barrett Connor, E ^p   Laughlin, G A ^p   Kabuto, M ^q   Akiba, S ^r   Stevens, R G ^s   Neriishi, K ^t   Land, C E ^f   Cauley, J A ^u   Kuller, L H ^u   Cummings, S R ^v   Helzlsouer, K J ^w   Alberg, A J ^w   Bush, T L ^w   Comstock, G W ^w   Gordon, G B ^x   Miller, S R ^w   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g Cancer Research   (United Kingdom)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY AT BUFFALO   (United States)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^r KAGOSHIMA UNIVERSITY   (Japan)

^s UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^t RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^u UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^x JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE SULFATE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CLINICAL TRIAL; META ANALYSIS; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 0042412430     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg022     Document Type: Article

References (38)

1. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
2. International Agency for Research on Cancer (IARC). Weight and weight control: breast cancer. In: IARC Handbooks of Cancer Prevention. Weight control and physical activity. Lyon France: IARC Press; 2002. p. 95-112.
3. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
4. Judd HL, Shamonki IM, Frumar AM, Lagasse LD. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 1982;59:680-6.
5. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, editors. Banbury Report 8. Hormones and breast cancer. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1981. p. 87-106.
6. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
7. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533-9.
8. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, et al. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1997;6: 177-81.
9. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 1997;76:401-5.
10. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
11. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
12. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 1997;145:1030-8.
13. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-6.
14. Barrett-Connor E, Friedlander NJ, Khaw KT. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 1990;50:6571-4.
15. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135:1220-30.
16. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 2000;9:575-9.
17. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1999;130:270-7.
18. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 1990;50:3859-62.
19. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
20. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-9.
21. StataCorp. 2001. Stata Statistical Software: Release 7.0. College Station, TX. Stata Corporation.
22. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561-5.
23. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000;152:950-64.
24. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.
25. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
26. Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001;60:81-9.
27. Potischman N, Gail MH, Troisi R, Wacholder S, Hoover RN. Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones. Epidemiology 1999;10:76-9.
28. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87: 1297-302.
29. Lukanova A, Toniolo P, Akhmedkhanov A, Hunt K, Rinaldi S, Zeleniuch-Jacquotte A, et al. A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 2001;10:443-52.
30. McGuire WL, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 1992;84:1336-41.
31. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, et al. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 2002;13:307-16.
32. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8.
33. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996;7:605-25.
34. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 2002;156:349-52.
35. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.
36. Manjer J, Kaaks R, Riboli E, Berglund G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project. Eur J Cancer Prev 2001;10:33-42.
37. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
38. Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002;13:325-32.